Previous close | 119.43 |
Open | 120.26 |
Bid | 0.00 x 1100 |
Ask | 0.00 x 900 |
Day's range | 119.18 - 121.41 |
52-week range | 102.00 - 149.25 |
Volume | |
Avg. volume | 1,416,648 |
Market cap | 24.816B |
Beta (5Y monthly) | 1.02 |
PE ratio (TTM) | 24.75 |
EPS (TTM) | 4.88 |
Earnings date | 02 May 2024 |
Forward dividend & yield | 0.96 (0.79%) |
Ex-dividend date | 27 Mar 2024 |
1y target est | 137.17 |
Within the Hips business, Zimmer Biomet (ZBH) is expected to have witnessed procedure volume recovery, banking on strategic product launches in the first quarter.
The latest partnership allows Smith+Nephew (SNN) to complement its existing implant range with the cutting-edge navigation technology of NAVBIT.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.